NEW YORK (GenomeWeb) – BioMérieux today said that the US Food and Drug Administration has given 510(k) clearance to its BioFire Diagnostics business for the FilmArray Respiratory Panel 2 (RP2), which tests for 17 viruses and four bacteria that are responsible for respiratory tract infections.

The panel will be commercially available in the US by mid-June, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.